Tasmania leads renewable energy charge
Tasmania, the home state of Marinova, met its 100% renewable energy target in late 2020. Read more
Latest news
Maritech® fucoidan promising for future atopic dermatitis treatment
Fucoidan may be a useful topical agent to assist in the future management of atopic dermatitis. Read more
Immune health evidence summarised
Global interest in natural ingredients that are backed by credible scientific evidence is surging - fucoidan is no exception. Read more
International Seaweed Symposium to be held in Australia
Details of the 24th International Seaweed Symposium are now available. Read more
Marinova champions Australian organic industry
Marinova's commitment to the organic industry, and to sustainable manufacturing, was recently highlighted in Australian Organic Connect magazine. Read more
2021: On the beauty shelf
Trust in science has increased, the link between nature and science is taking on greater relevance, calls for a green recovery from the pandemic are amplifying, and consumers are looking to brands to safeguard their health alongside that of the planet. Read more
Fucoidan shown to increase muscle size and strength
A new study has demonstrated that oral supplementation of the unique marine polysaccharide fucoidan may increase both muscle size and muscle strength. Read more
Spotlight on fucoidan history
A digital timeline detailing the history of fucoidan-containing seaweeds as well as fucoidan isolation, extraction and research is now available on Marinova’s website. Read more
Fucoidan inhibiting norovirus
Norovirus infections are a leading cause of epidemic and sporadic gastroenteritis worldwide. There are currently no preventative vaccines or antiviral treatments. Read more
Fucoidan: A review of its potential in limiting viral lung damage
A new Australian review discusses recent research into the potential for the marine polysaccharide fucoidan to assist in limiting lung damage that is often caused by respiratory viral infections. Read more